INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 92.00
-4.00 (-4.17%)
Aug 25, 2026, 4:11 PM GMT
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 97.6 million as of August 25, 2026. Its market cap has increased by 118.18% in one year.
Market Cap
97.60M
Enterprise Value
141.39M
Revenue
191.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
92.00
ChartMarket Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 97.60M, a decrease of -29.25%. That is a compound annual growth rate of -5.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 97.60M | 34.27% |
| Dec 31, 2025 | 72.70M | 57.14% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.83B |
| GSK plc | 75.75B |
| Haleon | 32.58B |
| Smith & Nephew | 9.10B |
| Scancell Holdings | 118.80M |
| Diaceutics | 118.41M |
| EKF Diagnostics Holdings | 109.35M |
| Faron Pharmaceuticals Oy | 91.98M |